Logo image of KMDA

KAMADA LTD (KMDA) Stock Fundamental Analysis

USA - NASDAQ:KMDA - IL0010941198 - Common Stock

6.65 USD
-0.28 (-4.04%)
Last: 11/20/2025, 3:17:41 PM
Fundamental Rating

6

Taking everything into account, KMDA scores 6 out of 10 in our fundamental rating. KMDA was compared to 533 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KMDA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make KMDA suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year KMDA was profitable.
KMDA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
KMDA had a positive operating cash flow in 4 of the past 5 years.
KMDA Yearly Net Income VS EBIT VS OCF VS FCFKMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

KMDA's Return On Assets of 5.16% is amongst the best of the industry. KMDA outperforms 91.74% of its industry peers.
With an excellent Return On Equity value of 7.31%, KMDA belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
KMDA has a better Return On Invested Capital (6.18%) than 92.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KMDA is significantly below the industry average of 19.19%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(6.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.16%
ROE 7.31%
ROIC 6.18%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
KMDA Yearly ROA, ROE, ROICKMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

KMDA has a Profit Margin of 11.21%. This is amongst the best in the industry. KMDA outperforms 92.31% of its industry peers.
In the last couple of years the Profit Margin of KMDA has declined.
With an excellent Operating Margin value of 14.89%, KMDA belongs to the best of the industry, outperforming 93.25% of the companies in the same industry.
In the last couple of years the Operating Margin of KMDA has declined.
KMDA has a Gross Margin of 43.62%. This is in the better half of the industry: KMDA outperforms 74.30% of its industry peers.
In the last couple of years the Gross Margin of KMDA has grown nicely.
Industry RankSector Rank
OM 14.89%
PM (TTM) 11.21%
GM 43.62%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
KMDA Yearly Profit, Operating, Gross MarginsKMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KMDA is destroying value.
Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
KMDA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KMDA has a worse debt to assets ratio.
KMDA Yearly Shares OutstandingKMDA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KMDA Yearly Total Debt VS Total AssetsKMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.27 indicates that KMDA is not in any danger for bankruptcy at the moment.
The Altman-Z score of KMDA (3.27) is better than 72.42% of its industry peers.
KMDA has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
The Debt to FCF ratio of KMDA (0.36) is better than 95.12% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, KMDA is in line with its industry, outperforming 41.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Altman-Z 3.27
ROIC/WACC0.71
WACC8.69%
KMDA Yearly LT Debt VS Equity VS FCFKMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 4.00 indicates that KMDA has no problem at all paying its short term obligations.
KMDA's Current ratio of 4.00 is in line compared to the rest of the industry. KMDA outperforms 47.28% of its industry peers.
A Quick Ratio of 2.21 indicates that KMDA has no problem at all paying its short term obligations.
KMDA's Quick ratio of 2.21 is on the low side compared to the rest of the industry. KMDA is outperformed by 70.36% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 2.21
KMDA Yearly Current Assets VS Current LiabilitesKMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
KMDA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.60% yearly.
The Revenue has grown by 12.93% in the past year. This is quite good.
The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%

3.2 Future

The Earnings Per Share is expected to grow by 26.83% on average over the next years. This is a very strong growth
KMDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.34% yearly.
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KMDA Yearly Revenue VS EstimatesKMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
KMDA Yearly EPS VS EstimatesKMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.47 indicates a rather expensive valuation of KMDA.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
KMDA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.47, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.40, which indicates a correct valuation of KMDA.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.56% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.42. KMDA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.47
Fwd PE 15.4
KMDA Price Earnings VS Forward Price EarningsKMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 97.37% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KMDA is valued cheaper than 97.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.14
EV/EBITDA 8.64
KMDA Per share dataKMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as KMDA's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y26.83%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.92%, KMDA has a reasonable but not impressive dividend return.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 69.85. KMDA pays more dividend than 98.87% of the companies in the same industry.
KMDA's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KMDA Yearly Dividends per shareKMDA Yearly Dividends per shareYearly Dividends per share 2025 0.05 0.1 0.15

5.3 Sustainability

DPN/A
EPS Next 2Y28.87%
EPS Next 3Y26.83%
KMDA Yearly Income VS Free CF VS DividendKMDA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

KAMADA LTD

NASDAQ:KMDA (11/20/2025, 3:17:41 PM)

6.65

-0.28 (-4.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-03 2026-03-03/bmo
Inst Owners10.9%
Inst Owner Change3.18%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap383.57M
Revenue(TTM)160.95M
Net Income(TTM)19.01M
Analysts84.44
Price Target15.05 (126.32%)
Short Float %0.16%
Short Ratio0.74
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2025-03-17 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.66%
Min EPS beat(2)1.67%
Max EPS beat(2)45.66%
EPS beat(4)4
Avg EPS beat(4)19.74%
Min EPS beat(4)1.67%
Max EPS beat(4)45.66%
EPS beat(8)7
Avg EPS beat(8)31.91%
EPS beat(12)10
Avg EPS beat(12)19.39%
EPS beat(16)10
Avg EPS beat(16)-93.5%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)2.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)5
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)8.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)0%
EPS NY rev (3m)16.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 18.47
Fwd PE 15.4
P/S 2.26
P/FCF 12.14
P/OCF 9.56
P/B 1.48
P/tB 1.67
EV/EBITDA 8.64
EPS(TTM)0.36
EY5.41%
EPS(NY)0.43
Fwd EY6.49%
FCF(TTM)0.55
FCFY8.24%
OCF(TTM)0.7
OCFY10.46%
SpS2.94
BVpS4.51
TBVpS3.98
PEG (NY)0.37
PEG (5Y)N/A
Graham Number6.04
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 7.31%
ROCE 7.83%
ROIC 6.18%
ROICexc 7.78%
ROICexgc 8.82%
OM 14.89%
PM (TTM) 11.21%
GM 43.62%
FCFM 18.63%
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.36
Debt/EBITDA 0.24
Cap/Depr 58.03%
Cap/Sales 5.03%
Interest Coverage 35.45
Cash Conversion 100.46%
Profit Quality 166.16%
Current Ratio 4
Quick Ratio 2.21
Altman-Z 3.27
F-Score6
WACC8.69%
ROIC/WACC0.71
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
EBIT growth 1Y50%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.93%
EBIT Next 3Y35.01%
EBIT Next 5YN/A
FCF growth 1Y387.49%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y257.57%
OCF growth 3YN/A
OCF growth 5Y11.54%

KAMADA LTD / KMDA FAQ

Can you provide the ChartMill fundamental rating for KAMADA LTD?

ChartMill assigns a fundamental rating of 6 / 10 to KMDA.


Can you provide the valuation status for KAMADA LTD?

ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.


Can you provide the profitability details for KAMADA LTD?

KAMADA LTD (KMDA) has a profitability rating of 7 / 10.


Can you provide the financial health for KMDA stock?

The financial health rating of KAMADA LTD (KMDA) is 6 / 10.


Can you provide the expected EPS growth for KMDA stock?

The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 50.06% in the next year.